Literature DB >> 6830166

Occurrence of oligoclonal bands in multiple sclerosis and other CNS diseases.

J R Miller, A M Burke, C T Bever.   

Abstract

The results of cerebrospinal fluid agarose gel electrophoresis in 300 consecutive patients were correlated with neurological examinations and diagnoses, other cerebrospinal fluid studies, and the results of evoked potential examinations. The presence of oligoclonal bands was the most sensitive test for multiple sclerosis (MS); bands were present in from 100% (11/11) of patients with definite MS to 82% (27/33) of those with possible MS (classified by McAlpine criteria). The visual evoked response was the next most sensitive study. Thirty-eight patients without MS or related disorders had bands in the IgG region. Three patients had plasma cell dyscrasias. Seven patients had thick single bands. Single bands did not correlate with chronic polyneuropathy but appeared to be an artifact of storage. Twenty-eight patients had active neurological disease, including cerebral infarction (in 5), viral infection (in 4), remote effect of carcinoma (in 4), and acute and chronic polyneuropathies (in 6). In acute illnesses (i.e., vascular insults), repeat electrophoresis showed disappearance of bands. In continually active disease, bands persisted. These results indicate that the presence of oligoclonal bands provides sensitive supporting evidence for the diagnosis of MS but that bands may be present in other disorders, including those not directly related to infection or abnormal immune response. The data suggest that oligoclonal bands may represent an immune response to neurological injury that is prominent in disorders with a particularly intense or continuous antigenic stimulus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6830166     DOI: 10.1002/ana.410130112

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  13 in total

Review 1.  Immunology of amyotrophic lateral sclerosis.

Authors:  N R Cashman; M E Gurney; J P Antel
Journal:  Springer Semin Immunopathol       Date:  1985

2.  A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band.

Authors:  Diana Ferraro; Diego Franciotta; Roberta Bedin; Claudio Solaro; Eleonora Cocco; Mario Santangelo; Paolo Immovilli; Alberto Gajofatto; Massimiliano Calabrese; Massimiliano Di Filippo; Riccardo Orlandi; Anna Maria Simone; Francesca Vitetta; Elisabetta Capello; Debora Giunti; Alessandra Murialdo; Jessica Frau; Sara Mariotto; Antongiulio Gallina; Claudio Gasperini; Patrizia Sola
Journal:  J Neurol       Date:  2017-04-05       Impact factor: 4.849

3.  Bronchiectasis with ulcerative colitis and myelopathy.

Authors:  W R Gibb; D P Dhillon; K J Zilkha; P J Cole
Journal:  Thorax       Date:  1987-02       Impact factor: 9.139

4.  Immunoglobulin G in multiple sclerosis brain.

Authors:  T Hosokawa; J C Hunt; J J Marchalonis; E L Hogan
Journal:  Metab Brain Dis       Date:  1988-09       Impact factor: 3.584

Review 5.  Linking autoantigen properties to mechanisms of immunity.

Authors:  J Daniel Griffin; Jimmy Y Song; Joshua O Sestak; Brandon J DeKosky; Cory J Berkland
Journal:  Adv Drug Deliv Rev       Date:  2020-04-20       Impact factor: 15.470

6.  Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behçet's disease involving the nervous system.

Authors:  B N McLean; D Miller; E J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-05       Impact factor: 10.154

7.  Immunoglobulin M in the cerebrospinal fluid: an indicator of recent immunological stimulation.

Authors:  M K Sharief; E J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-08       Impact factor: 10.154

Review 8.  CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies.

Authors:  A Arévalo-Martín; D García-Ovejero; O Gómez; A Rubio-Araiz; B Navarro-Galve; C Guaza; E Molina-Holgado; F Molina-Holgado
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

9.  Clinical significance of serum and CSF findings in the Guillain-Barré syndrome and related disorders.

Authors:  O G Segurado; H Krüger; H G Mertens
Journal:  J Neurol       Date:  1986-08       Impact factor: 4.849

10.  CFS oligoclonal bands in MS and other neurological diseases detected by agarose isoelectric focusing and electrophoresis.

Authors:  D Cerrato; A Salmaggi; C Ariano; L La Mantia; A Nespolo
Journal:  Ital J Neurol Sci       Date:  1984-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.